Type
1.
Wijeratne MP, Østbye T. Knowledge, attitudes and practices relating to leprosy among public health care providers in Colombo, Sri Lanka. Leprosy review [Internet]. 2017;88(1):75-84. Available from: https://leprosyreview.org/article/88/1/07-5084
Type
1.
Ibikunle PO, Nwokeji SC. Assessment of stigma among people living with Hansen’s disease in south-east Nigeria. Leprosy review [Internet]. 2017;88(1):43-57. Available from: https://leprosyreview.org/article/88/1/04-3057
Type
1.
Peters R, van Brakel WH, Lusli M, Damayanti R, Bunders J, Dadun. Cultural validation of a new instrument to measure leprosy-related stigma: the SARI Stigma Scale. Leprosy review [Internet]. 2017;88(1):23-42. Available from: https://leprosyreview.org/article/88/1/02-3042
Type
1.
Vieira MCA, Nery JS, Paixão E, Freitas de Andrade KV, Penna GO, Teixeira MG. Leprosy in children under 15 years of age in Brazil: A systematic review of the literature. PLoS neglected tropical diseases [Internet]. 2018;12(10):e0006788. Available from: https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0006788&type=printable
Type
1.
Rodrigues GA, QUALIO NP, Innocentini LMAR, Macedo LD, Cipriani Frade M, Motta ACF. Oral Manifestation of Leprosy: A Clinicopathologic Study of 13 Cases. Oral surgery, oral medicine, oral pathology and oral radiology. 2018;126(3):e42.
Type
1.
Nyffenegger N, Rupp K, Rhodes S, Nyffenegger N, Rupp K. Legible Leprosy: Skin Disease in the Testament of Cresseid, Chaucer’s Summoner, and Amis and Amiloun. In: [Internet]. Berlin, Boston: De Gruyter; 2018. pp. 77-93. Available from: https://books.google.nl/books?hl=nl&lr=&id=3I1uDwAAQBAJ&oi=fnd&pg=PA77&dq=leprosy&ots=ZTZI22f8LB&sig=sbrK6OwovxgK5XsBI9nXNhXVRqQ#v=onepage&q=leprosy&f=false
Type
1.
Wijesinghe MSD Health Promotion Bureau, Ministry of Health, Sri Lanka\vspace *{-4pt}. Web-based health databases and real-time GIS-based disease surveillance for leprosy control: fighting ancient evil with modern tools. Journal of the College of Community Physicians of Sri Lanka [Internet]. 2018;24(2):123-6. Available from: https://www.researchgate.net/profile/Supun_Wijesinghe/publication/327743376_Web-based_health_databases_and_real-time_GIS-based_disease_surveillance_for_leprosy_control_fighting_ancient_evil_with_modern_tools/links/5ba1c2cc45851574f7d58a4f/Web-based-health
Type
1.
Global leprosy update, 2013; reducing disease burden. Releve epidemiologique hebdomadaire [Internet]. 2014;89(36):389-400. Available from: http://www.who.int/wer/2014/wer8936.pdf
Type
1.
Akkerman L. The Quantitative Cultural Validation of Three Tools among People Affected by Leprosy in West Java, Indonesia. VU University Amsterdam. 2016. p. 53.
Type
1.
Joseph, Ponnaiya, Das, Chaitanya, Arumugam, Ebenezer. Evaluation of anti-bacterial activity of Rifapentine, Clarithromycin, Minocycline, Moxifloxacin, Ofloxacin and their combinations in Murine Model of Rifampicin Resistant Leprosy. Indian journal of leprosy [Internet]. 2016;88(3):147-58. Available from: http://www.ijl.org.in/2016/2%20Joseph%20et%20al%20(147-158).pdf